Investing in a global pooled-funding mechanism for late-stage clinical trials of poverty-related and neglected diseases: an economic evaluation.

Zimmerman, Armand; Diab, Mohamed Mustafa; Schäferhoff, Marco; McDade, Kaci Kennedy; Yamey, Gavin; Ogbuoji, Osondu

Zimmerman, Armand; Diab, Mohamed Mustafa; Schäferhoff, Marco; McDade, Kaci Kennedy; Yamey, Gavin; Ogbuoji, Osondu.

Affiliation

Zimmerman A; Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, North Carolina, USA.
Diab MM; Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, North Carolina, USA.
Schäferhoff M; Open Consultants, Berlin, Germany.
McDade KK; Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, North Carolina, USA.
Yamey G; Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, North Carolina, USA.
Ogbuoji O; Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, North Carolina, USA osondu.ogbuoji@duke.edu.

BMJ Glob Health ; 8(5)2023 05.

Article in En | MEDLINE | ID: mdl-37247874

Subject(s)
Key words

Health economics; Health policy; Infections, diseases, disorders, injuries

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neglected Diseases / Cost-Effectiveness Analysis Type of study: Health_economic_evaluation Aspects: Determinantes_sociais_saude / Patient_preference Limits: Humans Language: En Journal: BMJ Glob Health Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google